Drug Markets/Nelfinavir Mesylate

Nelfinavir Mesylate

1 NDC across 1 manufacturer|0 Generic,1 Brand

Nelfinavir Mesylate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Mar 14, 1997. In 2024, Medicare Part D spent $705K on Nelfinavir Mesylate across 515 claims for 64 beneficiaries.

Nelfinavir Mesylate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $9.72 to $9.72 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$9.72 – $9.72

per EA

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing NELFINAVIR MESYLATE

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
VIRACEPT 625 MG TABLET
$9.7224
per EA
—

Frequently Asked Questions

What is Nelfinavir Mesylate used to treat?

Nelfinavir Mesylate is used to treat acquired immunodeficiency syndrome, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Nelfinavir Mesylate?

In 2024, Medicare Part D spent $705K on Nelfinavir Mesylate across 515 claims for 64 beneficiaries.

How many Nelfinavir Mesylate products are on the market?

The Nelfinavir Mesylate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Nelfinavir Mesylate?

NADAC reference prices for Nelfinavir Mesylate range from $9.7224 to $9.7224 per EA.

Which manufacturers make Nelfinavir Mesylate?

1 manufacturer lists Nelfinavir Mesylate in NADAC. Ranked by number of NDCs, the largest are AGOURON (1).